Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Zori Comba, A."'
Autor:
Zori Comba, A., Blajman, C., Richardet, E., Bella, S., Vilanova, M., Cóppola, F., Van Kooten, M., Rodger, J., Giglio, R., Balbiani, L., Perazzo, F., Montiel, M., Chacón, M., Pujol, F., Mickiewicz, E., Cazap, E., Recondo, G., Lastiri, F., Simon, J., Wasserman, E. *, Schmilovich, A.
Publikováno v:
In European Journal of Cancer May 2001 37(8):1006-1013
Autor:
Graciela Caccia, Jeannette Rodger, Celia Brosio, Elizabeth Mickiewicz, Luis Riva Gonzáles, Luis Balbiani, Daniel Flores Morales, Carlos Delfino, Alberto Zori Comba
Publikováno v:
Oncology. 66:18-23
Objectives: To assess the efficacy and tolerability of gemcitabine and paclitaxel as first-line treatment in advanced breast cancer. Methods: Patients with histologically confirmed metastatic or metastatic plus locally advanced breast cancer received
Autor:
Gonzalo Recondo, Elizabeth Mickiewicz, F. Pujol, M. Vilanova, M. Montiel, A. Zori Comba, Luis Balbiani, C. Blajman, A. Schmilovich, Eduardo Richardet, E. Cazap, F. Lastiri, J. Simon, E. Wasserman, S. Bella, M. Chacon, M. Van Kooten, F. Coppola, R. Giglio, Jeannette Rodger, F. Perazzo
Publikováno v:
European Journal of Cancer. 37:1006-1013
The aim of this study was to examine the efficacy and safety of both oxaliplatin as a single agent and oxaliplatin in combination with daily×5 bolus 5-fluorouracil and folinic acid (5-FU/FA, Mayo clinic regimen) in the first-line treatment of metast
Autor:
O Rodriguez Nievas, E Cazap, G Traine, H Vicente, A Zori Comba, S Sena, Mauro Orlando, M. Van Kooten, G Cinat
Publikováno v:
British Journal of Cancer
The activity and mild toxicity profile of single-agent gemcitabine therapy in untreated (chemonaive) patients with non-small-cell lung cancer (NSCLC) is well documented. This phase II trial was conducted to determine the objective tumour response rat
Autor:
Carlos, Delfino, Graciela, Caccia, Luis, Riva Gonzáles, Elizabeth, Mickiewicz, Jeannette, Rodger, Luis, Balbiani, Daniel, Flores Morales, Alberto, Zori Comba, Celia, Brosio
Publikováno v:
Oncology (Williston Park, N.Y.). 17(12 Suppl 14)
Gemcitabine (Gemzar) and paclitaxel exhibit good activity and good safety profiles when used alone and together in the treatment of advanced breast cancer. In a phase II trial, 45 patients with metastatic breast cancer received gemcitabine at 1,200 m
Autor:
Fernando Otero, José Milei, J. J. Ale, Guy Garay, Humberto O. Gugliotta, R. Storino, Alberto Zori Comba
Publikováno v:
Cardiovascular drugs and therapy. 4(6)
Adriamycin (ADM) is an effective antineoplastic drug. However, the amount of ADM that can be administered must be limited because of the risk of developing a severe dose-dependent cardiomyopathy. 4'Epi-adriamycin (4'ADM) is a new anthracycline analog
Autor:
A. Schmilovich, J. Polera, S. Bonicatto, C. Callejas, D. Lewi, O. Rivero, M. Lozano, M. Matiewjuk, E. Torello, A. Zori Comba
Publikováno v:
European Journal of Cancer. 35:S261
Autor:
Milei, Jose, Ale, J. J., Garay, Guy, Otero, Fernando, Zori Comba, Alberto, Gugliotta, Humberto O., Storino, Ruben A.
Publikováno v:
Cardiovascular Drugs and Therapy; November 1990, Vol. 4 Issue: 6 p1519-1523, 5p